Pattern formation is essential in the development of animals and plants. The central problem in the formation of patterns is how to translate the genetic information into a reliable way to get the specific spatial pattern of cell differentiation.
The stripes formed by the French national flag model are a classic example of developmental biology. Cell differentiation, represented by different colors of the French national flag, is caused by a gradient of signal molecules (morphology), i.e., in high, medium and low concentrations of the morphology of the "blue", "white" or "red" gene stripes are activated, respectively. How cellular gene regulatory networks (GRNS) respond to morphogenesis, in a concentration dependent manner, is a key issue in developmental biology. Synthetic biology is a promising new tool to construct the function and performance of the genetic engineering regulatory network (GRNS) from the first principle. This research developed a synthetic biology approach to establish some basic mechanisms behind the formation of the fringes.
In previous studies, and the behaviour of the predefined gene circuit was successfully constructed and model, but most of them on a case by case basis. In this study, published in nature, researchers at the EMBL / CRG systems biology research group, beyond the individual network, and to investigate the computational and synthetic mechanisms of the two sides in a complete set of 3 nodes that form a network of Escherichia coli. The approach combines experimental synthetic biology, led by Mark Isalan, and is now the head of the life sciences department and computational modeling of the, ICREA, Professor of research at the Imperial College London, and the, and in the head of the CRG multicellular systems biology laboratory.
"We have carried out very innovative and ambitious research: we have used a three step approach to effectively explore and create a successful synthetic gene circuit we created a theoretical framework for the detailed study of GRNS" - 2800 of the one hundred thousand version of the network is simulated by computer. Then, we successfully developed a synthetic network engineering system, and finally, we determined all the new experimental data to fit it with a single mathematical model, explained: "the corresponding author James Sharp.
First, Andrea Munteanu, co-author of the study, theory on the screen was found to produce desired behavior (formation of striation morphology gradient) all kinds of design. In this step, she found 4 fundamental - different mechanisms to form the stripes. Then, Yolanda Schaerli, first author of the study and successfully show the four network is the function through establish their in the bacterium Escherichia coli using the tools of synthetic biology. The third step is to validate the different mechanisms by fitting all experimental data to a mathematical model.
The success of this process allows the researchers to take a step to the formation of a deeper level of the design principles. They identified a simple network of 2 nodes - where the Striped gene is directly activated by both activation and inhibition from the morphology of the sensor gene - i.e., replication in its simplest form of stripe formation ability to control. They succeed in building the prototype of a stripe forming network, and eventually find that it can even display an "anti - Striped" phenotype.
"The combination of detailed computational modeling and synthetic biology is more efficient and more powerful than the establishment of a network of networks," said Mark Isalan, author of the. "Our approach provides synthetic biology as a novel and fast diet - a new science discipline that is designed to design a variety of useful biological systems".
Read more:http://about.cusabio.com/m-179.html
2015年8月18日星期二
2015年8月17日星期一
Lab grown tissue
Lab grown tissue may one day provide a new therapy for the joints, including the joints, cartilage, tendons and ligaments.
Cartilage, for example, is the cap bone end, and allows the joint to work smoothly and hard materials. Biomedical engineer, University of California at Davis, explores how to work harder to engineer cartilage, and maintain a strong body of nature, in the journal reports on new progress, this week's proceedings of the National Academy of Sciences.
"Is a problem with the tissue engineering, mechanical properties in far different from natural organization," Ailaifusailiao MAKRIS, a postdoctoral fellow in biomedical engineering at the University of California, Davis, and first author on the said. Makris is Professor A. Athanasiou Kyriacos, a professor of Biomedical Engineering and Department of orthopedics surgery for the outstanding teaching, biomedical engineering, and under the supervision of the.
While the engineered cartilage has not been tested or approved for human use, the current approach to the treatment of severe joint problems is associated with the transplantation of natural cartilage. But it is well known that the method is not sufficient for a long-term clinical solution, Makris.
The main component of the cartilage is a collagen, which also provides the strength and flexibility of the organization, including ligaments, tendons, skin and bones. Collagen is produced by the cells and by the long fiber, which can be cross-linked together.
Engineering new cartilage
The Athanasiou group of researchers has been maintained in the laboratory by native cartilage and cartilage cultured cells, cartilage or, produced by engineered cartilage.
"The cells in the engineered tissue produce the initial immature matrix, and the process of maturation makes it more rigid," Makris said.
Knee joints are usually low in oxygen, so researchers are in the role of natural or engineered cartilage in depriving oxygen. In these two cases, low oxygen leads to more cross-linking and strong materials. They also found that the enzyme called ELISA, which is a test of the enzyme, was triggered by a low oxygen level, and promoted the cross-linking and made it stronger.
"The impact of the work presented in the proceedings of the National Academy of Sciences is a huge relative to the use of tissue grafts in surgery, as well as the use of tissue engineering, the principle of the new organization," Athanasiou said. Plants such as dead bodies, tendons, ligaments, or - the infamous loss of stored mechanical properties - are now in the development of the University of California at Davis, which makes them more powerful, full-featured technology, he said.
Athanasiou is also envisaged that many organizational engineering methods are now being changed to enhance the advantages of technology.
Read more:http://about.cusabio.com/m-187.html
Cartilage, for example, is the cap bone end, and allows the joint to work smoothly and hard materials. Biomedical engineer, University of California at Davis, explores how to work harder to engineer cartilage, and maintain a strong body of nature, in the journal reports on new progress, this week's proceedings of the National Academy of Sciences.
"Is a problem with the tissue engineering, mechanical properties in far different from natural organization," Ailaifusailiao MAKRIS, a postdoctoral fellow in biomedical engineering at the University of California, Davis, and first author on the said. Makris is Professor A. Athanasiou Kyriacos, a professor of Biomedical Engineering and Department of orthopedics surgery for the outstanding teaching, biomedical engineering, and under the supervision of the.
While the engineered cartilage has not been tested or approved for human use, the current approach to the treatment of severe joint problems is associated with the transplantation of natural cartilage. But it is well known that the method is not sufficient for a long-term clinical solution, Makris.
The main component of the cartilage is a collagen, which also provides the strength and flexibility of the organization, including ligaments, tendons, skin and bones. Collagen is produced by the cells and by the long fiber, which can be cross-linked together.
Engineering new cartilage
The Athanasiou group of researchers has been maintained in the laboratory by native cartilage and cartilage cultured cells, cartilage or, produced by engineered cartilage.
"The cells in the engineered tissue produce the initial immature matrix, and the process of maturation makes it more rigid," Makris said.
Knee joints are usually low in oxygen, so researchers are in the role of natural or engineered cartilage in depriving oxygen. In these two cases, low oxygen leads to more cross-linking and strong materials. They also found that the enzyme called ELISA, which is a test of the enzyme, was triggered by a low oxygen level, and promoted the cross-linking and made it stronger.
"The impact of the work presented in the proceedings of the National Academy of Sciences is a huge relative to the use of tissue grafts in surgery, as well as the use of tissue engineering, the principle of the new organization," Athanasiou said. Plants such as dead bodies, tendons, ligaments, or - the infamous loss of stored mechanical properties - are now in the development of the University of California at Davis, which makes them more powerful, full-featured technology, he said.
Athanasiou is also envisaged that many organizational engineering methods are now being changed to enhance the advantages of technology.
Read more:http://about.cusabio.com/m-187.html
2015年8月14日星期五
Escape from the yeast can improve the health benefits of wine, reduce headache after
Scientists at the University of Illinois have designed the "escape" of the yeast, which can greatly improve the health benefits of wine, while reducing the toxic byproducts that cause you to have a headache.
"Fermented foods - such as beer, wine and bread - are made with yeast strains, which means that they contain multiple copies of the gene in the genome, and it has been difficult to do so. If you are the one copy in the genome changes a gene, a constant copy will correct has changed one eye, "permanent Sujin, I microbial genomics of associate professor, main research personnel in the energy Biosciences Institute U shape that.
Recently, scientists have developed a "genomic knife" that spans multiple copies of the target gene in the genome of a very precise - until all copies are cut off. Jinyi group has used this enzyme using ELISA test kits and RNA directed cas9 nucleic acid, polyploid precise metabolic engineering of Saccharomyces cerevisiae has is widely used in wine, beer, and industrial fermentation strains.
The possibility of improving the nutritional value of the food is amazing, he said. "Wine, for example, contains a healthy component of resveratrol, along with the engineered yeast, we can increase the amount of Resveratrol by 10 times more than the amount of resveratrol, but it also can be added to the metabolic pathway for the introduction of other foods that are biologically active compounds, e.g.. Such as ginseng, into the wine yeast or we can pull for beer into the pathway of resveratrol production, sour milk, cheese, pickles, pickles or yeast strains - use yeast fermentation production of any food.
Another advantage is that the wine maker can clone enzymes to improve the lactic acid fermentation, the two fermentation process, so that the wine is smooth. To produce toxic byproducts of lactic acid fermentation is not correct, may cause the symptoms of a hangover, he said.
Kim stressed the importance of the genome knife as a tool that allows genetic engineers to make these extremely precise mutations.
"Scientists need to create design mutations to determine the function of a particular gene," he explained. "We have a great taste for wine production, and we want to know why. We removed a gene and then went to a different flavor, and we knew we had isolated the genes responsible for this."
The new technology also makes it less offensive to genetically modified organisms, he said. "In the past, scientists had to use antibiotic markers to indicate the genetic changes in the light spot in organisms, and many people against their use in dangerous food because of developing antibiotic resistance, and as a genomic knife can cut the genome very accurately and efficiently, so we don't have to use antibiotic markers to identify a genetic event".
The study is reported in the recent issue of environmental microbiology.
Read more:http://about.cusabio.com/m-179.html
"Fermented foods - such as beer, wine and bread - are made with yeast strains, which means that they contain multiple copies of the gene in the genome, and it has been difficult to do so. If you are the one copy in the genome changes a gene, a constant copy will correct has changed one eye, "permanent Sujin, I microbial genomics of associate professor, main research personnel in the energy Biosciences Institute U shape that.
Recently, scientists have developed a "genomic knife" that spans multiple copies of the target gene in the genome of a very precise - until all copies are cut off. Jinyi group has used this enzyme using ELISA test kits and RNA directed cas9 nucleic acid, polyploid precise metabolic engineering of Saccharomyces cerevisiae has is widely used in wine, beer, and industrial fermentation strains.
The possibility of improving the nutritional value of the food is amazing, he said. "Wine, for example, contains a healthy component of resveratrol, along with the engineered yeast, we can increase the amount of Resveratrol by 10 times more than the amount of resveratrol, but it also can be added to the metabolic pathway for the introduction of other foods that are biologically active compounds, e.g.. Such as ginseng, into the wine yeast or we can pull for beer into the pathway of resveratrol production, sour milk, cheese, pickles, pickles or yeast strains - use yeast fermentation production of any food.
Another advantage is that the wine maker can clone enzymes to improve the lactic acid fermentation, the two fermentation process, so that the wine is smooth. To produce toxic byproducts of lactic acid fermentation is not correct, may cause the symptoms of a hangover, he said.
Kim stressed the importance of the genome knife as a tool that allows genetic engineers to make these extremely precise mutations.
"Scientists need to create design mutations to determine the function of a particular gene," he explained. "We have a great taste for wine production, and we want to know why. We removed a gene and then went to a different flavor, and we knew we had isolated the genes responsible for this."
The new technology also makes it less offensive to genetically modified organisms, he said. "In the past, scientists had to use antibiotic markers to indicate the genetic changes in the light spot in organisms, and many people against their use in dangerous food because of developing antibiotic resistance, and as a genomic knife can cut the genome very accurately and efficiently, so we don't have to use antibiotic markers to identify a genetic event".
The study is reported in the recent issue of environmental microbiology.
Read more:http://about.cusabio.com/m-179.html
2015年8月13日星期四
Genes may help to reduce pollution
Genetically modified crops of long-term opponents, from the fear of the potential of traditional crops and other plant pollution. Now scientists at the University of Guelph have discovered that a plant gene may help to reduce the risk of farmers' GM contamination, and to quell the argument against the use of genetically modified crops, said Sharif Sharif, a new research paper, the results of the main authors.
This is considered to be the first study ever to find genes involved in altering the normal cross pollination of fruit trees - the need for one plant to another fertilization - into self - pollination, said Sheriff.
The paper was published in the Journal BMC biology.
Sheriff said the researchers may have one day to insert the gene into GM crops, to prevent its pollen from reaching other plants.
Plant a professor of agriculture at the Jay Subramanian, Nawaz Sharif, student mentor and the co-author, said: "there are a lot of global GM crops from creating a 'them to fertilization in wild populations and about the pollen. Super weed. "
Researchers have found that a genetically made protein is naturally a very small number of plants that are self - pollination and fruit. Peach, for example, have been receiving flowers, unlike those in need of pollen of another tree tree fertilization and set the fruit showy flowers of plum and cherry's cousin.
Subramanian study of fruit trees in the vineyard research and innovation center of the vineyard, Ontario province. Sheriff had worked with him on the study of plants to stress, such as drought or disease.
In the paper co authors are at the University of Guelph professor jaideep Mathur, molecular and cell biology department and Gopi Paliyath plants Agiruclture system. With the Islamic El-Sharkawy, had any researcher Arvind Subramanian with; and colleagues at the National University of Singapore.
In addition to helping farmers and food producers, their findings could be a boon for the perfume maker, Subramanian said.
In the use of perennial such as jasmine, the gene may keep off the flowers, let growers to collect more by perfume maker valuable aromatic compounds. "When the peaks of volatile compounds," Subramanian said. "When the flowers bloom, you lose almost 80% of the proportion of volatile substances."
Most plants develop open flowers that attract pollination, but it takes energy to make flowers as well as nectar and pollen. Subramanian said that the closure of flowers and plants - known as the closed flower fertilization, or Greece's "closed marriage" - may be in the development of a lack of pollination media environment or adverse conditions.
"This is the first time that we have known that it has been shown that the use of molecular tools can induce the closure of flowers and plants," he said.
Read more:http://www.cusabio.com/catalog-13-1.html
This is considered to be the first study ever to find genes involved in altering the normal cross pollination of fruit trees - the need for one plant to another fertilization - into self - pollination, said Sheriff.
The paper was published in the Journal BMC biology.
Sheriff said the researchers may have one day to insert the gene into GM crops, to prevent its pollen from reaching other plants.
Plant a professor of agriculture at the Jay Subramanian, Nawaz Sharif, student mentor and the co-author, said: "there are a lot of global GM crops from creating a 'them to fertilization in wild populations and about the pollen. Super weed. "
Researchers have found that a genetically made protein is naturally a very small number of plants that are self - pollination and fruit. Peach, for example, have been receiving flowers, unlike those in need of pollen of another tree tree fertilization and set the fruit showy flowers of plum and cherry's cousin.
Subramanian study of fruit trees in the vineyard research and innovation center of the vineyard, Ontario province. Sheriff had worked with him on the study of plants to stress, such as drought or disease.
In the paper co authors are at the University of Guelph professor jaideep Mathur, molecular and cell biology department and Gopi Paliyath plants Agiruclture system. With the Islamic El-Sharkawy, had any researcher Arvind Subramanian with; and colleagues at the National University of Singapore.
In addition to helping farmers and food producers, their findings could be a boon for the perfume maker, Subramanian said.
In the use of perennial such as jasmine, the gene may keep off the flowers, let growers to collect more by perfume maker valuable aromatic compounds. "When the peaks of volatile compounds," Subramanian said. "When the flowers bloom, you lose almost 80% of the proportion of volatile substances."
Most plants develop open flowers that attract pollination, but it takes energy to make flowers as well as nectar and pollen. Subramanian said that the closure of flowers and plants - known as the closed flower fertilization, or Greece's "closed marriage" - may be in the development of a lack of pollination media environment or adverse conditions.
"This is the first time that we have known that it has been shown that the use of molecular tools can induce the closure of flowers and plants," he said.
Read more:http://www.cusabio.com/catalog-13-1.html
2015年8月12日星期三
Anti HIV new drug development
In the study, scientists from Australia found that three of the HIV fragmentation - 1 reverse transcriptase inhibitors, can effectively inhibit the activity of HIV - 1 reverse transcriptase, for the prevention and treatment of HIV - 1 drug development provides an important information.
In the study of saturation transfer, the researchers used magnetic resonance imaging (MRI), and in the experimental method of in vitro activity, found the viral fragment 1 reverse transcriptase inhibitors (NNRTI) and reverse transcriptase inhibitors (NRTI) compared to the chemical structure and mechanism of action of the fragment is completely different.
Researchers identified three compounds can inhibit HIV RNA and DNA dependent DNA polymerase activity of reverse transcriptase, in micro friction levels of concentration, but still retains the suppression mutation in the reverse transcriptase enzyme, including three mutations in the NNRTI resistant effect: K103N, Y181C and G190A.These synthetic compounds could inhibit mouse Moloney leukemia virus, retroviral activity, but EC on our production: oli DNA polymerase I Klenow fragment no inhibitory effect.
The researchers also analyzed the dynamic balance, the results showed that one of the fragments is the special effect of HIV - 1 reverse transcriptase inhibitors, on the dNTP substrate, and the other is a compound of a competitive inhibitor, DNA template by the special effects of reverse transcription polymerase activity / primer, and so the compound also inhibits RNA activity of H.In, this dNTP competitive reverse transcriptase inhibitor NRTI M184V.In and other anti viral test activity, the study of the template / primer can inhibit HIV - 1 copies.
To sum up, the study found that 1 of the fragments with a combination of three pieces of screening with anti HIV method - the discovery of HIV prevention and treatment of powerful functions.The fragment 1 reverse transcriptase activity - provides a new opportunity for the development of new drugs has a very important significance.
Read more:http://about.cusabio.com/m-179.html
In the study of saturation transfer, the researchers used magnetic resonance imaging (MRI), and in the experimental method of in vitro activity, found the viral fragment 1 reverse transcriptase inhibitors (NNRTI) and reverse transcriptase inhibitors (NRTI) compared to the chemical structure and mechanism of action of the fragment is completely different.
Researchers identified three compounds can inhibit HIV RNA and DNA dependent DNA polymerase activity of reverse transcriptase, in micro friction levels of concentration, but still retains the suppression mutation in the reverse transcriptase enzyme, including three mutations in the NNRTI resistant effect: K103N, Y181C and G190A.These synthetic compounds could inhibit mouse Moloney leukemia virus, retroviral activity, but EC on our production: oli DNA polymerase I Klenow fragment no inhibitory effect.
The researchers also analyzed the dynamic balance, the results showed that one of the fragments is the special effect of HIV - 1 reverse transcriptase inhibitors, on the dNTP substrate, and the other is a compound of a competitive inhibitor, DNA template by the special effects of reverse transcription polymerase activity / primer, and so the compound also inhibits RNA activity of H.In, this dNTP competitive reverse transcriptase inhibitor NRTI M184V.In and other anti viral test activity, the study of the template / primer can inhibit HIV - 1 copies.
To sum up, the study found that 1 of the fragments with a combination of three pieces of screening with anti HIV method - the discovery of HIV prevention and treatment of powerful functions.The fragment 1 reverse transcriptase activity - provides a new opportunity for the development of new drugs has a very important significance.
Read more:http://about.cusabio.com/m-179.html
2015年8月11日星期二
Statins improve the risk of memory decline
Recently, a study published in JAMA in the United States from the United States, statins and do not take cholesterol lowering drugs directly call or related individuals and statins in memory to loss.When statins and 30 days to lower the cholesterol statins, compared to patients with no medication, medication of patients with memory loss occurred.
But the researchers said the Medical Association, because patients are often associated with medical conditions and drug efficacy, it is convenient for doctors to find their memory loss symptoms, in the use of statins to describe a number of cases and acute memory loss directly related, but the study shows that long-term use of statins to improve individual memory or memory of individuals are not.
The researchers compared the use of statins in two patients and the other 482543 control groups: non lipid lowering drugs (LLDs) 482543 individuals and 26484 non statin drugs, such as the test to the study of the amino acid, chlorine, hydrochloric acid test as the ester, etc.; at the same time, the researchers also conducted a cross study of two cases, the use of diagnostic criteria, personal memory loss related data.
The researchers compared statin users and any personal cholesterol lowering drugs. After 30 days of treatment with statins, the risk of memory decline began, and that any individual cholesterol lowering drugs were not personal, and the researchers found that the drug was associated with an increased risk of memory loss after 30 days.
Finally, the researchers said, the experiment, or all of the drugs will cause acute individual memory loss, which is likely to lead to memory loss, and may be related to the possibility of testing bias, bias and the possibility of testing may be very high, late, of course, the study will be tested in patients with preventive treatment, such as patients taking cholesterol lowering drugs.
Read more:http://about.cusabio.com/m-177.html
But the researchers said the Medical Association, because patients are often associated with medical conditions and drug efficacy, it is convenient for doctors to find their memory loss symptoms, in the use of statins to describe a number of cases and acute memory loss directly related, but the study shows that long-term use of statins to improve individual memory or memory of individuals are not.
The researchers compared the use of statins in two patients and the other 482543 control groups: non lipid lowering drugs (LLDs) 482543 individuals and 26484 non statin drugs, such as the test to the study of the amino acid, chlorine, hydrochloric acid test as the ester, etc.; at the same time, the researchers also conducted a cross study of two cases, the use of diagnostic criteria, personal memory loss related data.
The researchers compared statin users and any personal cholesterol lowering drugs. After 30 days of treatment with statins, the risk of memory decline began, and that any individual cholesterol lowering drugs were not personal, and the researchers found that the drug was associated with an increased risk of memory loss after 30 days.
Finally, the researchers said, the experiment, or all of the drugs will cause acute individual memory loss, which is likely to lead to memory loss, and may be related to the possibility of testing bias, bias and the possibility of testing may be very high, late, of course, the study will be tested in patients with preventive treatment, such as patients taking cholesterol lowering drugs.
Read more:http://about.cusabio.com/m-177.html
2015年8月10日星期一
Reports: Scientific novel nano drug, specific killer tumor cells!
Recently, a study in the Journal Reports Dalhousie, researchers at Scientific medical school, developed a new way of delivering chemotherapy drugs. Using nano technology, the new drug delivery system is only in tumor cells to release the drug, thereby protecting healthy cells from damage. The research was published in the Journal Reports Scientific.
Dr. Puvvada Naga, a blogger at New Brunswick Dalhousie (DMNB), invented the drug delivery system. He collaborated with Brunt DMNB, Keith, and researchers in the United States and India to develop the new system.
The team has designed a nano particle that can increase the amount of chemotherapy drugs delivered to the tumor cells, and only release chemotherapy drugs within the tumor cells. This reduces the impact of health organizations to a minimum.
Tumor cells produce a high level of acid, which can activate the nanoparticles, thus allowing them to enter the tumor cells, the release of drugs. When nano particles release the drug, its color will change, that is, the light conversion. This light conversion can help researchers understand how many chemotherapy drugs have been released, and identify the presence of a tumor.
"We design originality is fluorescent light conversion potential clinical possibility of transformation, because it helps to detect chemotherapy drug release. "Dr. Puvvada said. "We will still have a lot of work to do before this technology is used in the clinic because the current fluorescence can't be detected by CTs or MRIs. This is our next step. "
Although the study is carried out on human breast cancer cells, the technology has the potential to be used in any solid tumor.
"Although this new drug delivery system is still in its early stages, it is promising to become a method of individual treatment for patients. "Dr. Brunt, assistant professor of pharmacology. "This target to good, and can detect drug release amount of treatment, there is the potential to improve the quality of life of patients with solid tumors, the overall effect of their just around the corner. "
Read more:http://www.cusabio.com/catalog-13-1.html
Dr. Puvvada Naga, a blogger at New Brunswick Dalhousie (DMNB), invented the drug delivery system. He collaborated with Brunt DMNB, Keith, and researchers in the United States and India to develop the new system.
The team has designed a nano particle that can increase the amount of chemotherapy drugs delivered to the tumor cells, and only release chemotherapy drugs within the tumor cells. This reduces the impact of health organizations to a minimum.
Tumor cells produce a high level of acid, which can activate the nanoparticles, thus allowing them to enter the tumor cells, the release of drugs. When nano particles release the drug, its color will change, that is, the light conversion. This light conversion can help researchers understand how many chemotherapy drugs have been released, and identify the presence of a tumor.
"We design originality is fluorescent light conversion potential clinical possibility of transformation, because it helps to detect chemotherapy drug release. "Dr. Puvvada said. "We will still have a lot of work to do before this technology is used in the clinic because the current fluorescence can't be detected by CTs or MRIs. This is our next step. "
Although the study is carried out on human breast cancer cells, the technology has the potential to be used in any solid tumor.
"Although this new drug delivery system is still in its early stages, it is promising to become a method of individual treatment for patients. "Dr. Brunt, assistant professor of pharmacology. "This target to good, and can detect drug release amount of treatment, there is the potential to improve the quality of life of patients with solid tumors, the overall effect of their just around the corner. "
Read more:http://www.cusabio.com/catalog-13-1.html
订阅:
博文 (Atom)
